GHRP-2: Dosage, Protocol, and Research Guide
Second-generation growth hormone releasing peptide with moderate appetite effects
Mechanism
More potent ghrelin receptor agonist than GHRP-6 with better GH release profile. Less appetite stimulation due to more selective receptor binding. Minimal effect on cortisol and prolactin.
Protocol at a glance
| Starting dose | 100mcg |
|---|---|
| Maintenance dose | 100-300mcg |
| Maximum dose | 300mcg |
| Frequency | 1-3 times daily |
| Typical duration | 3-6 month cycles |
| Route | Subcutaneous |
| Injection site | Abdomen or thigh |
| Timing | On empty stomach |
Side effects
- Mild appetite increase
- Water retention
- Transient fatigue
Contraindications
- Active cancer
- Pregnancy
Protocol notes
- Less appetite stimulation than GHRP-6
- Good for lean muscle gain
- May increase cortisol slightly
- More potent than GHRP-6 for GH release
Frequently asked questions
What is GHRP-2 and how does it work?
GHRP-2 is a second-generation growth hormone releasing peptide that acts as a ghrelin receptor agonist. Through selective receptor binding, GHRP-2 stimulates the body's natural growth hormone secretion more potently than first-generation peptides like GHRP-6. The selective binding mechanism allows for enhanced GH release while producing less appetite stimulation and minimal effects on cortisol and prolactin compared to less selective compounds.
How does GHRP-2 compare to GHRP-6?
GHRP-2 is significantly more potent than GHRP-6 for growth hormone release due to its more selective ghrelin receptor binding. The key practical difference is that GHRP-2 produces substantially less appetite stimulation than GHRP-6, making it preferable for individuals concerned about appetite effects. GHRP-2 also delivers a superior GH release profile and shows minimal effect on cortisol and prolactin levels.
What are the side effects of GHRP-2?
GHRP-2 side effects are generally mild and include mild appetite increase, water retention, and transient fatigue. These effects are considerably less pronounced than those associated with less selective growth hormone secretagogues. Most users report that side effects diminish as the body adapts over the course of a research cycle. Individual responses vary, and GHRP-2 may cause slight cortisol elevation in some cases.
What is the correct GHRP-2 dosing protocol?
Standard GHRP-2 protocols begin with a starting dose of 100 micrograms, with maintenance dosing ranging from 100 to 300 micrograms per injection. The maximum recommended dose is 300 micrograms. Administration frequency ranges from once to three times daily depending on protocol objectives. All injections must be administered on an empty stomach via subcutaneous injection to the abdomen or thigh for optimal absorption and efficacy.
How long should a GHRP-2 cycle last?
GHRP-2 research cycles typically span three to six months, allowing sufficient time to assess changes in growth hormone markers and body composition endpoints. This duration provides adequate time to observe the peptide's effects while maintaining safety margins. Cycle length may be adjusted based on individual response and specific research objectives, though adequate recovery time between cycles is important.
Who should not use GHRP-2?
GHRP-2 is contraindicated in individuals with active cancer, as growth hormone stimulation may affect cancer progression. The peptide is also contraindicated during pregnancy. GHRP-2 is not FDA-approved for human use and is for research purposes only. Before considering use, consult a licensed physician to ensure GHRP-2 is appropriate for your specific health situation and medical history.
Can I stack GHRP-2 with other compounds?
Research on GHRP-2 stacking protocols remains limited in published literature. GHRP-2 is sometimes combined with other growth hormone secretagogues or peptides in research settings, but specific stacking protocols should be developed within the context of your particular research objectives and with appropriate medical supervision. Any combination should be carefully evaluated for potential interactions.
What should I monitor while using GHRP-2?
Research on specific monitoring parameters for GHRP-2 remains limited. Given its mechanism as a growth hormone secretagogue, reasonable parameters to monitor may include growth hormone levels, IGF-1, cortisol, prolactin, and standard metabolic panels. Regular monitoring helps assess individual response and detect changes in key markers. Work with a healthcare provider to establish appropriate monitoring protocols for your specific research protocol.
More Growth Hormone Peptides peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.